Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

Pharma Chatbots

Smarter, Compliant Engagement: Why Pharma is Warming Up to Chat-Based Solutions

Pharma marketers are embracing chat-based tools to engage HCPs and patients faster, simplify PI sharing, and gain real-time insights — all while staying ABPI and GDPR compliant. When aligned with...

Genetic Digital

- PMLiVE

Takeda’s Adzynma approved by MHRA for rare blood clotting disorder cTTP

The enzyme replacement therapy is now the first treatment approved in the UK for this patient population

- PMLiVE

AstraZeneca announces positive phase 3 results for Imfinzi in high-risk bladder cancer

Around half of NMIBC patients are classed as being high-risk for disease progression or recurrence

- PMLiVE

Novo Nordisk’s GLP-1 drug Wegovy shows early protection against heart disease

Heart and circulatory diseases are responsible for more than 170,000 deaths in the UK every year

- PMLiVE

Transforming Global Market Access: Smarter Resource Management with Local Affiliates – A Live Webinar

Are your global market access resources scattered, leading to inconsistencies and confusion among your affiliates? Join us live at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT) on Wednesday 21st May, to discover how...

Petauri Evidence

New team members

Cuttsy+Cuttsy welcomes new team members and celebrates a familiar face returning

Cuttsy+Cuttsy proudly announces the expansion of its team with the addition of three new hires—Michelle, Jay, and Emily—and the welcome return of former team member Sally as Account Director.

Cuttsy + Cuttsy

- PMLiVE

FDA approves Verastem Oncology’s combination therapy for rare ovarian cancer type

Approximately 6,000 to 8,000 women in the US are living with low-grade serous ovarian cancer

- PMLiVE

J&J/Protagonist’s icotrokinra shows promise in difficult-to-treat plaque psoriasis

An estimated eight million people in the US are living with the immune-mediated skin disease

- PMLiVE

GSK shares promising phase 3 results for linerixibat in PBC-related itch

Pruritus is experienced by up to 90% of patients with the rare liver disease

- PMLiVE

Shaping the Future of Hematology and Women’s Health

Changes in the healthcare world are likely to limit opportunities for young researchers, especially women.Three leaders in hematology — Belinda Avalos, Sarah O’Brien, and Marty Liggett — share the initiatives...

Medscape Education

- PMLiVE

BeiGene’s Tevimbra combination granted EC approval in small cell lung cancer

Approximately 15% of all lung cancer patients are diagnosed with the aggressive disease

- PMLiVE

Inizio Evoke appoints Tristen George and Kevin Kaniuga as executive creative directors

The dual appointments are aimed at strengthening Evoke’s creative leadership

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links